[⁶⁸ Ga]Ga-PSMA-11 in diagnosis and follow-up after transarterial chemoembolization in hepatocellular carcinoma

Affiliations

¹ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.
² 2Nd Department of Clinical Radiology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland. kacper.pelka@wum.edu.pl.
⁴ Department of Methodology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. kacper.pelka@wum.edu.pl.
⁵ Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.

Jolanta Kunikowska et al. Eur J Nucl Med Mol Imaging. 2023 Dec.

. 2023 Dec;51(1):314-315.

doi: 10.1007/s00259-023-06372-4. Epub 2023 Aug 5.

¹ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland.
² 2Nd Department of Clinical Radiology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Nuclear Medicine, Medical University of Warsaw, Warsaw, Poland. kacper.pelka@wum.edu.pl.
⁴ Department of Methodology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland. kacper.pelka@wum.edu.pl.
⁵ Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

1. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi: 10.1056/NEJMra1713263. - DOI - PubMed
1. Rizzo A, Dall’Armellina S, Pizzuto DA, Perotti G, Zagaria L, Lanni V, Treglia G, Racca M, Annunziata S. PSMA radioligand uptake as a biomarker of neoangiogenesis in solid tumours: diagnostic or theragnostic factor? Cancers (Basel) 2022;14(16):4039. doi: 10.3390/cancers14164039. - DOI - PMC - PubMed
1. Kunikowska J, Cieślak B, Gierej B, Patkowski W, Kraj L, Kotulski M, Zieniewicz K, Królicki L. [68 Ga]Ga-prostate-specific membrane antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(3):883–892. doi: 10.1007/s00259-020-05017-0. - DOI - PMC - PubMed
1. Rizzo A, Racca M, Albano D, Dondi F, Bertagna F, Annunziata S, Treglia G. Can PSMA-targeting radiopharmaceuticals be useful for detecting hepatocellular carcinoma using positron emission tomography? An updated systematic review and meta-analysis. Pharmaceuticals (Basel) 2022;15(11):1368. doi: 10.3390/ph15111368. - DOI - PMC - PubMed
1. Hirmas N, Leyh C, Sraieb M, Barbato F, Schaarschmidt BM, Umutlu L, Nader M, Wedemeyer H, Ferdinandus J, Rischpler C, Herrmann K, Costa PF, Lange CM, Weber M, Fendler WP. 68Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma. J Nucl Med. 2021;62(9):1235–1241. doi: 10.2967/jnumed.120.257915. - DOI - PMC - PubMed